Insulin degludec does not compromise efficacy or safety when given in a flexible once-daily dosing regimen compared to insulin glargine once daily at the same time each day in type 2 diabetes Article

Web of Science: 000307671300113
Industry Collaboration International Collaboration

Cited authors

  • Atkin, S. L.; Bain, S. C.; Gough, S.; Shestakova, M. V.; Raz, I.; Blonde, L.; Meneghini, L.; Begtrup, K.; Johansen, T.; Birkeland, K. I.

Publication date

  • 2011

Published in

International Standard Serial Number (ISSN)

  • 0012-186X

Start page

  • S53

End page

  • S53

Volume

  • 54